Biotivia Labs Are Offering a Proprietary Acetylated Resveratrol To The Health Community

954 views

Print |

Acetylated resveratrol available to

New York City, N.Y, May 10, 2011 — Biotivia Labs, a world leading developer and supplier of resveratrol and pterostilbene based health supplements, is offering their super critical extracted natural acetylated resveratrol to the worlds medical and the scientific community. Biotivia calls this highly bioactive, soluble molecule Resveratrol Alpha.

Through facilitating an exchange of knowledge amongst researchers, Biotivia’s objective is to help further the study and research of resveratrol and the ever expanding role it is expected to play in preventing and treating many age related illnesses.

Acetylation of resveratrol holds promise as one of the first anti-radiation medicines for human populations. Its advantages over resveratrol are that it is water soluble, more stable and it converts to resveratrol when metabolized by the body. This means that a single dose of acetylated resveratrol helps it reach the brain more quickly and cross the brain blood barrier. This makes the resveratrol’s effects more intense and increases it effectiveness.

James Betz, founder and CEO of Biotivia, said: “With our level of commitment to increasing the knowledge and applications of resveratrol, we have come up with another world first. With Biotivia’s proprietary acetylated resveratrol produced with our own super critical extraction process and purified in our GMP facility we have overcome one of the major challenges of resveratrol’s bio-availability.

This molecule will offer researchers and consumers the opportunity to dramatically improve the bio availability, plasma concentration, and membrane penetration properties of trans-resveratrol. We anticipate strong interest in Resveratrol Alpha by both informed consumers and the research institutions Biotivia collaborates with. Our studies clearly show major advantages for the use of Resveratrol Alpha in human clinical trials for a variety of conditions which have shown positive therapeutic response to Transmax, our trans-resveratrol product”

Presently, there are several private institutions and public organisations that are conducting human clinical trials in which Biotivia’s resveratrol supplements or compounds are being used. Some of these include the Albert Einstein Medical Center, Northumberland University, University of Ferrara, Torino University, the NIH, Health Canada and many others.

Betz continues: “Biotivia produces all of its materials and products in pharmaceutical facilities, not supplement mills as do other companies. Furthermore, we go to extremes to protect our advanced compounds from oxidation and deterioration by UV, heat and other environmental factors. We use no additives, expanders, glidants, or other extraneous fillers in any of our products, consequently researchers have a purified form of resveratrol and all of its analogs available for their investigations.”

To read more about acetylated resveratrol please visit Biotivia Labs

###

About Biotivia LLC

Biotivia was established in 1992 in Vienna, Austria as a supplier of natural raw materials and biologically active botanics to the supplement and functional food industries and to researchers and scientific institutions worldwide. The company evolved into one of the world’s leading developers and suppliers of unique science-based nutritional supplements and award winning skin care therapies, with most of their products centered around the use of concentrated resveratrol and complementary botanical extracts.

Biotivia presently has US offices in New York, Los Angeles, Kansas City and international offices in the UK, Spain, Austria, Denmark, Italy, Germany, Singapore, Xi’an, China and Mumbai, India.

Beyond its strong consumer base, the company currently supplies researchers, physicians and scientists at Harvard, Stanford, Yale, Georgetown, The Albert Einstein Medical Center, University of Texas, M.D. Anderson Cancer Center, Health Canada, and the University of California. Transmax and Bioforte in particular are being investigated by several major university medical schools as a possible treatment for a variety of conditions that seriously impair the health and well being of millions of people around the world. Biotivia most recently signed an agreement to supply Transmax to the University of Ferrara for use in three human clinical trials in Italy and Egypt on its possible use by Thalassemia sufferers as an alternative to the whole blood transfusions which such patients now require monthly. The Albert Einstein Medical College published a study which elucidated the beneficial effects of Biotivia’s proprietary resveratrol on glucose tolerance and mitochondria function in pre-diabetic subjects. Bioforte was also shown to more than double brain blood flow in a study done at the University of Northumbria in the UK.

Biotivia’s resveratrol products, Transmax and Bioforte, have been independently assessed by Consumer Labs, the leading American quality watchdog, and were deemed both ‘most potent’ and ‘best value’. Transmax has been certified as an investigational drug by the NIH, an endorsement of its safety and purity.

Most of Biotivia’s supplements have been certified Vegan by the American Vegetarian Association.

Important Caveat: Neither PteroMax nor any Biotivia product has been definitively shown to diagnose, prevent or cure any age related diseases. PteroMax is not intended to diagnose, prevent, treat or cure any disease. Studies done in vitro and on animals do not always translate into the same biological effect when taken by human subjects. The statements herein have not been reviewed or approved by the US FDA. All Biotivia supplements are manufactured in state of the art government inspected pharmaceutical facilities in accordance with CGMP and USP standards.